Literature DB >> 9934346

Compliance in hypertension: why don't patients take their pills?

M G Myers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9934346      PMCID： PMC1229949     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Results from CMA's huge 1998 physician survey point to a dispirited profession.

Authors:  P Sullivan; L Buske
Journal:  CMAJ       Date:  1998-09-08       Impact factor: 8.262

2.  Information technology and the future of medical education.

Authors:  R J Sebaldt
Journal:  Clin Invest Med       Date:  1997-12       Impact factor: 0.825

3.  Persistence with treatment for hypertension in actual practice.

Authors:  J J Caro; M Salas; J L Speckman; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

4.  Awareness, treatment, and control of hypertension in Canada.

Authors:  M R Joffres; P Ghadirian; J G Fodor; A Petrasovits; A Chockalingam; P Hamet
Journal:  Am J Hypertens       Date:  1997-10       Impact factor: 2.689

Review 5.  Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.

Authors:  F H Leenen; T W Wilson; P Bolli; P Larochelle; M Myers; S P Handa; G Boileau; J Tanner
Journal:  Can J Cardiol       Date:  1997-10       Impact factor: 5.223

6.  The consent form as a possible cause of side effects.

Authors:  M G Myers; J A Cairns; J Singer
Journal:  Clin Pharmacol Ther       Date:  1987-09       Impact factor: 6.875

Review 7.  Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.

Authors:  R I Ogilvie; E D Burgess; J R Cusson; R D Feldman; L A Leiter; M G Myers
Journal:  CMAJ       Date:  1993-09-01       Impact factor: 8.262

8.  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.

Authors:  J D Neaton; R H Grimm; R J Prineas; J Stamler; G A Grandits; P J Elmer; J A Cutler; J M Flack; J A Schoenberger; R McDonald
Journal:  JAMA       Date:  1993-08-11       Impact factor: 56.272

9.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

10.  Information technology and the clinical curriculum: some predictions and their implications for the class of 2003.

Authors:  J G Faughnan; R Elson
Journal:  Acad Med       Date:  1998-07       Impact factor: 6.893
View more
  9 in total

Review 1.  Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

Authors:  K A Payne; S Esmonde-White
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

Review 2.  Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension.

Authors:  M Ruzicka; F H Leenen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Quality of life with nonpharmacologic treatment of hypertension.

Authors:  J P Roel; C L Hildebrant; R H Grimm
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

4.  Adherence of patients to long-term medication: a cross-sectional study of antihypertensive regimens in Austria.

Authors:  Felix Lötsch; Lorenz Auer-Hackenberg; Mirjam Groger; Khalid Rehman; Valerie Morrison; Emily Holmes; Sahdia Parveen; Catrin Plumpton; Wendy Clyne; Sabina de Geest; Fabienne Dobbels; Bernard Vrijens; Przemyslaw Kardas; Dyfrig Hughes; Michael Ramharter
Journal:  Wien Klin Wochenschr       Date:  2015-04-24       Impact factor: 1.704

Review 5.  Methods and applications of quality-of-life measurement during antihypertensive therapy.

Authors:  M A Testa
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

6.  Regression of microalbuminuria in type 2 diabetics after switch to irbesartan treatment : an observational study in 38 016 patients in primary care.

Authors:  H Lehnert; P Bramlage; D Pittrow; W Kirch
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

7.  Efficacy and Safety of Valsartan 160mg/Hydrochlorothiazide 25mg Combination in Patients with Hypertension not Adequately Controlled by Valsartan 160mg/Hydrochlorothiazide 12.5mg.

Authors:  Peter Trenkwalder; Hans-Joachim Ulmer; Gottfried Weidinger; Renate Handrock
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 8.  Updates to Adherence to Hypertension Medications.

Authors:  Paola C Roldan; Grant Y Ho; P Michael Ho
Journal:  Curr Hypertens Rep       Date:  2018-04-10       Impact factor: 5.369

9.  Management of high-risk patients with hypertension and left ventricular hypertrophy in Germany: differences between cardiac specialists in the inpatient and outpatient setting.

Authors:  Heinz Völler; Frank J Sonntag; Joachim Thiery; Karl Wegscheider; Friedrich C Luft; Kurt Bestehorn
Journal:  BMC Public Health       Date:  2006-10-19       Impact factor: 3.295
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.